Close Menu

NEW YORK – Laboratory Corporation of America announced Monday an exclusive licensing agreement with Genfit to commercialize Genfit's NIS4 technology for patients with non-alcoholic steatohepatitis (NASH). 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.